top of page

Item List
As COVID Numbers Rise Again, VCs Continue To Be Bullish on Telehealth

Telehealth startup Cerebral entered the medical tech scene two years ago, backed by over $400 million in venture funding and a promise: remote access to mental health professionals and treatment that could help patients with a range of behavioral challenges, from depression to anxiety to ADHD, all bundled in a neat monthly subscription priced at $100 per month.

But by May of this year, Cerebral’s practices began to crumble under scrutiny. The company’s problems accelerated when an ex-executive filed a lawsuit in April alleging he was fired for speaking out against the Cerebral’s tendency to over-prescribe ADHD stimulants. The lawsuit then led to a Justice Department investigation into the company’s “possible violations” of the federal Controlled Substances Act, which is still pending alongside a separate inquiry from the Drug Enforcement Administration.

Recent Posts

Portfolio Company


Clario and Strados Labs partner to bring new pulmonary endpoints to respiratory ...

Strados Labs

Wavemaker 360 News


Wavemaker Three-Sixty Health Announces 2023 Council of Strategic Advisors to Sup ...


Wavemaker 360 News


MedTech Color investing in Black, brown leaders in medical technology world ...

Fox 11 News

surf break copy_edited_edited.jpg
bottom of page